140 related articles for article (PubMed ID: 32618683)
1. Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials.
Zheng W; Xiang YQ; Cai DB; Yang XH; Zhang L; Zheng W; Lu XB; Tong YM; Huang X; Ungvari GS; Sim K; Ning YP; Xiang YT
J Clin Psychopharmacol; 2020; 40(4):386-390. PubMed ID: 32618683
[TBL] [Abstract][Full Text] [Related]
2. Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia: A 12-week, randomized, double-blind, placebo-controlled study.
Lu ML; Chen TT; Kuo PH; Hsu CC; Chen CH
Schizophr Res; 2018 Mar; 193():126-133. PubMed ID: 28688742
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: a preliminary study.
Niitsu T; Fujisaki M; Shiina A; Yoshida T; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Fukami G; Nakazato M; Shirayama Y; Hashimoto K; Iyo M
J Clin Psychopharmacol; 2012 Oct; 32(5):593-601. PubMed ID: 22926591
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
Zheng W; Li XB; Shi ZM; Yang XH; Cai DB; Ng CH; Ungvari GS; Liu WJ; Wu YJ; Wang YY; Ning YP; Xiang YT
Pharmacopsychiatry; 2020 Jan; 53(1):5-13. PubMed ID: 31207653
[TBL] [Abstract][Full Text] [Related]
6. Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials.
Kishi T; Hirota T; Iwata N
Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):633-41. PubMed ID: 23605347
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Ning YP; Xiang YT
Eur Neuropsychopharmacol; 2018 Jan; 28(1):149-158. PubMed ID: 29174529
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
[TBL] [Abstract][Full Text] [Related]
9. Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
Zheng W; Wang S; Ungvari GS; Ng CH; Yang XH; Gu YH; Li M; Xiang YQ; Xiang YT
J Clin Psychopharmacol; 2017 Jun; 37(3):341-346. PubMed ID: 28383359
[TBL] [Abstract][Full Text] [Related]
10. The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review.
Polcwiartek C; Nielsen J
Psychopharmacology (Berl); 2016 Mar; 233(5):741-50. PubMed ID: 26626327
[TBL] [Abstract][Full Text] [Related]
11. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.
Saavedra-Velez C; Yusim A; Anbarasan D; Lindenmayer JP
J Clin Psychiatry; 2009 Jan; 70(1):104-12. PubMed ID: 19026265
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zhu XM; Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Wang XP; Kulkarni J; Grigg J; Ning YP; Xiang YT
Schizophr Res; 2018 Jul; 197():288-293. PubMed ID: 29395611
[TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study.
Silver H; Barash I; Aharon N; Kaplan A; Poyurovsky M
Int Clin Psychopharmacol; 2000 Sep; 15(5):257-61. PubMed ID: 10993127
[TBL] [Abstract][Full Text] [Related]
14. Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Li Z; Wang Y; Wang Z; Kong L; Liu L; Li L; Tang Y
Acta Psychiatr Scand; 2023 Apr; 147(4):360-372. PubMed ID: 36585771
[TBL] [Abstract][Full Text] [Related]
15. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY
J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
[TBL] [Abstract][Full Text] [Related]
17. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial.
Brown HE; Freudenreich O; Fan X; Heard SO; Goff D; Petrides G; Harrington AL; Kane JM; Judge H; Hoeppner B; Fava M; Perlis RH
JAMA Psychiatry; 2019 Jul; 76(7):691-699. PubMed ID: 30916714
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials.
Zheng W; Cai DB; Zhang QE; He J; Zhong LY; Sim K; Ungvari GS; Ning YP; Xiang YT
J Psychiatr Res; 2019 Jun; 113():27-33. PubMed ID: 30878789
[TBL] [Abstract][Full Text] [Related]
20. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
Correll CU; Maayan L; Kane J; Hert MD; Cohen D
J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
